Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD

NCT: NCT04676854 · ACTIVE_NOT_RECRUITING

NCT IDNCT04676854
StatusACTIVE_NOT_RECRUITING
Start Date2020-11-24
SponsorScience Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the efficacy and safety of the PRIMA System in patients with atrophic AMD. Eligible subjects will be implanted with the PRIMA Implant. The subjects will be assessed with various visual function and functional vision tests at defined timepoints throughout the clinical investigation with the PRIMA System (Implant and Visual Processor).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑